Patient preference trial comparing capecitabine and S-1 in metastatic breast cancer patients.
Status: Not yet recruiting
Phase of Trial: Phase II
Latest Information Update: 01 Jun 2014
Price : $35 *
At a glance
- Drugs Capecitabine (Primary) ; Gimeracil/oteracil/tegafur (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 01 Jun 2014 The study protocol presented at : 50th Annual Meeting of the American Society of Clinical Oncology.
- 05 Mar 2014 New trial record